NMP22

NMP22 is a nuclear matrix protein that is used as a biomarker in the detection of bladder cancer. It is a protein that is found in the nucleus of a cell and is involved in the organization and function of the cell's DNA. The level of NMP22 in the urine can be measured to help detect bladder cancer.

Overview

NMP22 is a nuclear matrix protein that is found in the nucleus of a cell. It is involved in the organization and function of the cell's DNA. The level of NMP22 in the urine can be measured to help detect bladder cancer. This is because the level of NMP22 is often higher in people with bladder cancer.

Use in Bladder Cancer Detection

The NMP22 test is a urine test that measures the level of NMP22. It is used to help detect bladder cancer. The test is often used in conjunction with other tests, such as a cystoscopy, to help diagnose bladder cancer.

The NMP22 test is not perfect and can sometimes give false positive or false negative results. Therefore, it is not used as the only method of diagnosing bladder cancer.

Limitations

While the NMP22 test can be a useful tool in the detection of bladder cancer, it does have some limitations. For example, it can sometimes give false positive results, meaning it can indicate that a person has bladder cancer when they do not. It can also give false negative results, meaning it can indicate that a person does not have bladder cancer when they do.

See Also

• Bladder cancer
• Biomarker
• Nuclear matrix protein
• Cystoscopy